entry – ActRelationshipCheckpoint
Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Global Markets
Biocon Biologics; Denosumab biosimilars; Vevzuo; Evfraxy; Europe market entry; Amgen settlement; biosimilars approval; European Commission; bone health; oncology